Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The mucin-type glycoprotein podoplanin is specifically expressed by lymphatic but not blood vascular endothelial cells in culture and in tumor-associated lymphangiogenesis, and podoplanin deficiency results in congenital lymphedema and impaired lymphatic vascular patterning. However, research into the biological importance of podoplanin has been hampered by the lack of a generally available antibody against the human protein, and its expression in normal tissues and in human malignancies has remained unclear. We generated a human podoplanin-Fc fusion protein and found that the commercially available mouse monoclonal antibody D2-40 specifically recognized human podoplanin, as assessed by enzyme-linked immunosorbent assay and Western blot analyses. We found that, in addition to lymphatic endothelium, podoplanin was also expressed by peritoneal mesothelial cells, osteocytes, glandular myoepithelial cells, ependymal cells, and by stromal reticular cells and follicular dendritic cells of lymphoid organs. These findings were confirmed in normal mouse tissues with anti-podoplanin antibody 8.1.1. Podoplanin was also strongly expressed by granulosa cells in normal ovarian follicles, and by ovarian dysgerminomas and granulosa cell tumors. Although podoplanin was primarily absent from normal human epidermis, its expression was strongly induced in 22 of 28 squamous cell carcinomas studied. These findings suggest a potential role of podoplanin in tumor progression, and they also identify the first commercially available antibody for the specific staining of a defined lymphatic marker in archival human tissue sections, thereby enabling more widespread studies of tumor lymphangiogenesis in human cancers.

Original publication

DOI

10.1016/S0002-9440(10)62311-5

Type

Journal article

Journal

Am J Pathol

Publication Date

03/2005

Volume

166

Pages

913 - 921

Keywords

Animals, Antibodies, Monoclonal, Blotting, Western, Carcinoma, Squamous Cell, Cell Line, Cell Line, Tumor, Dendritic Cells, Disease Progression, Enzyme-Linked Immunosorbent Assay, Epithelium, Female, Glycoproteins, Granulosa Cell Tumor, Granulosa Cells, Humans, Lymphatic System, Membrane Glycoproteins, Mice, Microscopy, Fluorescence, Mucins, Neoplasms, Germ Cell and Embryonal, Ovary, RNA, Small Interfering, Rats, Recombinant Fusion Proteins, Transfection, Up-Regulation